Medscape June 2, 2023
Continuous glucose monitors (CGMs) could enhance care of hospitalized people with diabetes, supplementing or possibly even replacing the use of finger sticks to draw blood to measure a patient’s glucose level. But that technological future will require ensuring that the monitoring devices are as accurate as the conventional method, experts told Medscape Medical News.
In 2020, the US Food and Drug Administration (FDA) enabled in-hospital use of CGMs to reduce contact between patients and healthcare providers during the COVID-19 pandemic. Diabetes is a risk factor for more severe COVID, meaning that many patients with the infection also required ongoing care for their blood sugar problems.
Prior to the pandemic, in-person finger-stick tests were the primary means of measuring glucose...
Today's Sponsors
Today's Sponsor